Xpreza 100 mg Injection is classified as an anti-metabolite medication, utilized in adults diagnosed with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. These disorders impact the bone marrow and can lead to complications in the production of normal blood cells.
Xpreza 100 mg Injection contains Azacitidine, which functions by inhibiting the growth of cancer cells. It supports the bone marrow in generating normal blood cells while eliminating abnormal cells present in the bone marrow.
Occasionally, Xpreza 100 mg Injection may lead to side effects such as nausea, vomiting, diarrhoea, constipation, weakness, headache, and reactions at the injection site. Most of these side effects are generally mild and may not necessitate medical intervention, often resolving on their own over time. However, do not hesitate to consult your doctor if any side effects persist or worsen.
Avoid using Xpreza 100 mg Injection if you are pregnant or breastfeeding. If you become pregnant while undergoing treatment with Xpreza 100 mg Injection, seek medical advice immediately. This medication is not advised for children, as its safety and efficacy have not been determined. Ensure you inform your doctor about your health status and any medications you are taking to prevent potential side effects or interactions.
